Eupraxia Pharmaceuticals (EPRX) Common Equity (2022 - 2026)
Eupraxia Pharmaceuticals' Common Equity came in at $129.67 million for the quarter ended Jun 30, 2026, up 518.2% from $20.98 million a year earlier but down 4.8% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Common Equity (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals' Common Equity was $80.45 million, up 152.7% from the prior year.
- Common Equity carries a three-year compound annual growth rate of 123.5% (years ended Dec 2022 to Dec 2025).
- Going back by year, Common Equity was $31.84 million in the year ended Dec 31, 2024, $892,326 in the year ended Dec 31, 2023 (-87.6%) and $7.21 million in the year ended Dec 31, 2022.
- The five-year range for quarterly Common Equity is $892,326 (the quarter ended Dec 31, 2023) to $136.19 million (the quarter ended Mar 31, 2026).
- Year-over-year, Common Equity has increased for three consecutive quarters, with growth averaging 236.2% over the last five quarters.
- Business Quant data shows EPRX's Common Equity at $136.19 million (quarter ended Mar 31, 2026), $80.45 million (quarter ended Dec 31, 2025) and $88.44 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - | 129.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 129.67 Mn |
| Mar 31, 2026 | 136.19 Mn |
| Dec 31, 2025 | 80.45 Mn |
| Sep 30, 2025 | 88.44 Mn |
| Jun 30, 2025 | 20.98 Mn |
| Mar 31, 2025 | 27.03 Mn |
| Dec 31, 2024 | 31.84 Mn |
| Sep 30, 2024 | 7.98 Mn |
| Jun 30, 2024 | 13.34 Mn |
| Mar 31, 2024 | 18.11 Mn |
| Dec 31, 2023 | 892,326.00 |
| Dec 31, 2022 | 7.21 Mn |
API Access
Eupraxia Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();